1.015

3.33% -0.035

After Hours: 1.015

Estrella Immunopharma Inc (ESLA)

Overview News Price History Discussions Forecast

Estrella Immunopharma Inc stock is currently priced at $1.015, with a 24-hour trading volume of 24,530. It has seen a -3.33% decreased in the last 24 hours and a -9.38% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $1.04 pivot point. If it approaches the $1.01 support level, significant changes may occur.

Previous Close:

$1.05

Open:

24h Volume:

24,530

Market Cap:

$37.16M

Revenue:

Net Income/Loss:

$-8.53M

P/E Ratio:

-8.705

EPS:

-0.1166

Net Cash Flow:

$-12.75M

1W Performance:

-6.02%

1M Performance:

-9.38%

6M Performance:

-18.81%

1Y Performance:

+0.00%

1D Range:

$0.86

$1.12

52W Range:

$0.86

$3.50

Estrella Immunopharma Inc Stock (ESLA) Company Profile

Name

Estrella Immunopharma Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

510 318 9098

Address

5858 Horton Street, Suite 170, EmeryVille

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ESLA's Discussions on Twitter

Estrella Immunopharma Inc Stock (ESLA) Latest News

Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances - InvestorPlace

InvestorPlace

Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket

Benzinga

Estrella Biopharma going public in SPAC merger - The Pharma Letter

The Pharma Letter

SPAC on track: Preclinical T-cell company Estrella latest in string of biotechs to take blank check route - Fierce Biotech

Fierce Biotech

OncoCyte Stock (NASDAQ:OCX), Quotes and News Summary - Benzinga

Benzinga

Estrella Immunopharma Inc Stock (ESLA) Financials Data

Estrella Immunopharma Inc (ESLA) Net Income 2024

ESLA net income (TTM) was -$8.53 million for the quarter ending December 31, 2023.

Estrella Immunopharma Inc (ESLA) Cash Flow 2024

ESLA recorded a free cash flow (TTM) of -$12.75 million for the quarter ending December 31, 2023.

Estrella Immunopharma Inc (ESLA) Earnings per Share 2024

ESLA earnings per share (TTM) was -$0.2434 for the quarter ending December 31, 2023.

Estrella Biopharma, Inc., a preclinical-stage biopharmaceutical company, develops cancer therapeutics. It develops CD19 and CD20-targeted T-cell therapies for the treatment of blood cancers and solid tumors. Estrella Biopharma, Inc. was incorporated in 2022 and is based in Emeryville, California.